Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2009.07.15, US 225805 P
2010.01.12, US 294426 P
ALAN RIGTER ET AL: "A Protective and Safe Intranasal RSV Vaccine Based on a Recombinant Prefusion-Like Form of the F Protein Bound to Bacterium-Like Particles", PLOS ONE, PUBLIC LIBRARY OF SCIENCE , vol. 8, no. 8 1 August 2013 (2013-08-01), pages e41072.1-e41072.14, XP002718926, ISSN: 1932-6203, DOI: 10.1371/JOURNAL.PONE.0071072 Retrieved from the Internet: URL:http://www.plosone.org/article/fetchOb ject.action?uri=info%3Adoi%2F10.1371%2Fjou rnal.pone.0071072&representation=PDF [retrieved on 2013-08-12] (B1)
ZIMMER GERT ET AL: "Cleavage at the furin consensus sequence RAR/KR109 and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture", 20020901, vol. 76, no. 18, 1 September 2002 (2002-09-01), pages 9218-9224, XP009002025, (B1)
DATABASE BIOSIS [Online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; June 2006 (2006-06), VALARCHER J -F ET AL: "Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R-109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves", Database accession no. PREV200600472306 & JOURNAL OF GENERAL VIROLOGY, vol. 87, no. Part 6, June 2006 (2006-06), pages 1659-1667, ISSN: 0022-1317(print), DOI: 10.1099/VIR.0.81755-0 (B1)
DIANA MART N ET AL: "Sequence elements of the fusion peptide of human respiratory syncytial virus fusion protein required for activity", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 87, 1 January 2006 (2006-01-01), pages 1649-1658, XP002600413, ISSN: 0022-1317, DOI: DOI:10.1099/VIR.0.81715-0 (B1)
J. S. MCLELLAN ET AL: "Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, vol. 342, no. 6158, 1 November 2013 (2013-11-01), pages 592-598, XP055391357, ISSN: 0036-8075, DOI: 10.1126/science.1243283 & J. S. MCLELLAN ET AL: "Supplementary Materials for Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus", SCIENCE, 31 October 2013 (2013-10-31), pages 1-30, XP055364874, ISSN: 0036-8075, DOI: 10.1126/science.1243283 (B1)
KRARUP A ET AL: "A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism", NATURE COMMUNICATIONS, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 6, 3 September 2015 (2015-09-03), pages 8143-1, XP002755858, ISSN: 2041-1723, DOI: 10.1038/NCOMMS9143 [retrieved on 2015-09-03] (B1)
LAMB ET AL: "Structural basis of viral invasion: lessons from paramyxovirus F", CURRENT OPINION IN STRUCTURAL BIOLOGY, ELSEVIER LTD, GB, vol. 17, no. 4, 1 August 2007 (2007-08-01) , pages 427-436, XP022273654, ISSN: 0959-440X, DOI: 10.1016/J.SBI.2007.08.016 (B1)
MCLELLAN JASON S ET AL: "Structural basis of respiratory syncytial virus neutralization by motavizumab", NATURE STRUCTURAL BIOL, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 17, no. 2, 1 February 2010 (2010-02-01), page 248, XP009133396, ISSN: 1072-8368, DOI: 10.1038/NSMB.1723 [retrieved on 2010-01-24] (B1)
SISSOËFF LUDMILLA ET AL: "Stable trimerization of recombinant rabies virus glycoprotein ectodomain is required for interaction with the p75NTR receptor", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 86, no. Pt 9, 1 September 2005 (2005-09-01), pages 2543-2552, XP002426506, ISSN: 0022-1317, DOI: 10.1099/VIR.0.81063-0 (B1)
VALARCHER J -F ET AL: "Bovine respiratory syncytial virus lacking the virokinin or with a mutation in furin cleavage site RA(R/K)R-109 induces less pulmonary inflammation without impeding the induction of protective immunity in calves", JOURNAL OF GENERAL VIROLOGY, vol. 87, no. Part 6, June 2006 (2006-06), pages 1659-1667, XP008136764, ISSN: 0022-1317 (B1)
WO-A1-03/083095 (B1)
WO-A1-2009/079796 (B1)
WO-A1-2010/077717 (B1)
WO-A2-2010/009277 (B1)
BEGONA RUIZ-ARGUELLO M ET AL: "Thermostability of the human respiratory syncytial virus fusion protein before and after activation: implications for the membrane-fusion mechanism", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, vol. 85, 1 January 2004 (2004-01-01), pages 3677-3687, XP007917291, ISSN: 0022-1317, DOI: DOI:10.1099/VIR.0.80318-0 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3178490)
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 15. avg. år (EP) | 2024.06.20 | 6310 | ANAQUA SERVICES | Betalt og godkjent |
Årsavgift 14. avg. år (EP) | 2023.06.22 | 4500 | ANAQUA SERVICES | Betalt og godkjent |
32208644 expand_more expand_less | 2022.06.27 | 5500 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|
||||
Årsavgift 13. avg. år (EP) | 2022.06.23 | 4200 | ANAQUA SERVICES | Betalt og godkjent |